NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will collaborate with Expression Pathology in applying their respective proteomic and microdissection technologies to measure cancer-related proteins in formalin-fixed paraffin-embedded tissue.

The collaboration will involve using Thermo Fisher's mass spectrometry technologies with Expression Pathology's laser microdissection and Liquid Tissue sample processing tools to study these proteins using an alternative to immunohistochemistry (IHC) and tissue morphology techniques.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.